CN114642236A - 一种可以辅助降血压的小球藻纳豆压片糖果 - Google Patents
一种可以辅助降血压的小球藻纳豆压片糖果 Download PDFInfo
- Publication number
- CN114642236A CN114642236A CN202210292633.9A CN202210292633A CN114642236A CN 114642236 A CN114642236 A CN 114642236A CN 202210292633 A CN202210292633 A CN 202210292633A CN 114642236 A CN114642236 A CN 114642236A
- Authority
- CN
- China
- Prior art keywords
- parts
- chlorella
- natto
- ginseng
- medlar
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000013557 nattō Nutrition 0.000 title claims abstract description 47
- 241000195649 Chlorella <Chlorellales> Species 0.000 title claims abstract description 44
- 235000009508 confectionery Nutrition 0.000 title claims abstract description 37
- 230000036772 blood pressure Effects 0.000 title claims abstract description 29
- 244000111489 Gardenia augusta Species 0.000 claims abstract description 32
- 108090000765 processed proteins & peptides Proteins 0.000 claims abstract description 32
- 241001264174 Cordyceps militaris Species 0.000 claims abstract description 30
- 230000001603 reducing effect Effects 0.000 claims abstract description 30
- 235000017784 Mespilus germanica Nutrition 0.000 claims abstract description 29
- 244000182216 Mimusops elengi Species 0.000 claims abstract description 29
- 235000000560 Mimusops elengi Nutrition 0.000 claims abstract description 29
- 244000046146 Pueraria lobata Species 0.000 claims abstract description 29
- 235000010575 Pueraria lobata Nutrition 0.000 claims abstract description 29
- 235000007837 Vangueria infausta Nutrition 0.000 claims abstract description 29
- 244000037364 Cinnamomum aromaticum Species 0.000 claims abstract description 28
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 claims abstract description 28
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims abstract description 28
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 28
- 108010073771 Soybean Proteins Proteins 0.000 claims abstract description 28
- 235000008434 ginseng Nutrition 0.000 claims abstract description 28
- 235000019710 soybean protein Nutrition 0.000 claims abstract description 27
- 235000018102 proteins Nutrition 0.000 claims abstract description 23
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 23
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 23
- 241000361919 Metaphire sieboldi Species 0.000 claims abstract description 18
- 239000002994 raw material Substances 0.000 claims abstract description 10
- 244000131316 Panax pseudoginseng Species 0.000 claims description 46
- 230000000694 effects Effects 0.000 claims description 41
- 235000003181 Panax pseudoginseng Nutrition 0.000 claims description 20
- 241000756042 Polygonatum Species 0.000 claims description 16
- 239000000843 powder Substances 0.000 claims description 15
- 238000002156 mixing Methods 0.000 claims description 10
- 238000007873 sieving Methods 0.000 claims description 10
- 238000001035 drying Methods 0.000 claims description 6
- 238000005520 cutting process Methods 0.000 claims description 5
- 238000004806 packaging method and process Methods 0.000 claims description 5
- 238000010298 pulverizing process Methods 0.000 claims description 5
- 241000243684 Lumbricus Species 0.000 claims description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 3
- 235000018958 Gardenia augusta Nutrition 0.000 claims description 2
- 238000000034 method Methods 0.000 claims description 2
- 210000004369 blood Anatomy 0.000 abstract description 22
- 239000008280 blood Substances 0.000 abstract description 22
- 210000003734 kidney Anatomy 0.000 abstract description 19
- 210000004185 liver Anatomy 0.000 abstract description 16
- 210000004204 blood vessel Anatomy 0.000 abstract description 8
- 210000004556 brain Anatomy 0.000 abstract description 8
- 230000036039 immunity Effects 0.000 abstract description 8
- 230000007774 longterm Effects 0.000 abstract description 6
- 239000009759 San-Chi Substances 0.000 abstract description 5
- 208000024172 Cardiovascular disease Diseases 0.000 abstract description 4
- 230000006378 damage Effects 0.000 abstract description 4
- 208000026106 cerebrovascular disease Diseases 0.000 abstract description 3
- 230000002526 effect on cardiovascular system Effects 0.000 abstract description 3
- 241000037831 Polygonatum sibiricum Species 0.000 abstract description 2
- 241000208340 Araliaceae Species 0.000 abstract 2
- 210000004072 lung Anatomy 0.000 description 16
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 12
- 239000000047 product Substances 0.000 description 12
- 230000001737 promoting effect Effects 0.000 description 10
- 208000007536 Thrombosis Diseases 0.000 description 9
- 230000006870 function Effects 0.000 description 8
- 210000000952 spleen Anatomy 0.000 description 8
- 208000024891 symptom Diseases 0.000 description 8
- 206010020772 Hypertension Diseases 0.000 description 7
- 206010011224 Cough Diseases 0.000 description 6
- 201000010099 disease Diseases 0.000 description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 6
- 235000019640 taste Nutrition 0.000 description 6
- 206010010774 Constipation Diseases 0.000 description 5
- 208000031971 Yin Deficiency Diseases 0.000 description 5
- 235000012000 cholesterol Nutrition 0.000 description 5
- 206010062717 Increased upper airway secretion Diseases 0.000 description 4
- 206010037660 Pyrexia Diseases 0.000 description 4
- 230000009286 beneficial effect Effects 0.000 description 4
- 230000007812 deficiency Effects 0.000 description 4
- 206010012601 diabetes mellitus Diseases 0.000 description 4
- 208000002173 dizziness Diseases 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 230000002708 enhancing effect Effects 0.000 description 4
- 208000026435 phlegm Diseases 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 239000003053 toxin Substances 0.000 description 4
- 231100000765 toxin Toxicity 0.000 description 4
- 108700012359 toxins Proteins 0.000 description 4
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 3
- 101710196208 Fibrinolytic enzyme Proteins 0.000 description 3
- 206010039966 Senile dementia Diseases 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 210000001124 body fluid Anatomy 0.000 description 3
- 239000010839 body fluid Substances 0.000 description 3
- 229910052791 calcium Inorganic materials 0.000 description 3
- 239000011575 calcium Substances 0.000 description 3
- 230000004438 eyesight Effects 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 239000008187 granular material Substances 0.000 description 3
- 238000005469 granulation Methods 0.000 description 3
- 230000003179 granulation Effects 0.000 description 3
- 230000002401 inhibitory effect Effects 0.000 description 3
- 210000000936 intestine Anatomy 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 210000003205 muscle Anatomy 0.000 description 3
- 230000002028 premature Effects 0.000 description 3
- 238000010926 purge Methods 0.000 description 3
- 238000010791 quenching Methods 0.000 description 3
- 230000001105 regulatory effect Effects 0.000 description 3
- 230000028327 secretion Effects 0.000 description 3
- 210000000582 semen Anatomy 0.000 description 3
- 230000035922 thirst Effects 0.000 description 3
- UUUHXMGGBIUAPW-UHFFFAOYSA-N 1-[1-[2-[[5-amino-2-[[1-[5-(diaminomethylideneamino)-2-[[1-[3-(1h-indol-3-yl)-2-[(5-oxopyrrolidine-2-carbonyl)amino]propanoyl]pyrrolidine-2-carbonyl]amino]pentanoyl]pyrrolidine-2-carbonyl]amino]-5-oxopentanoyl]amino]-3-methylpentanoyl]pyrrolidine-2-carbon Chemical compound C1CCC(C(=O)N2C(CCC2)C(O)=O)N1C(=O)C(C(C)CC)NC(=O)C(CCC(N)=O)NC(=O)C1CCCN1C(=O)C(CCCN=C(N)N)NC(=O)C1CCCN1C(=O)C(CC=1C2=CC=CC=C2NC=1)NC(=O)C1CCC(=O)N1 UUUHXMGGBIUAPW-UHFFFAOYSA-N 0.000 description 2
- 208000007848 Alcoholism Diseases 0.000 description 2
- 102000015427 Angiotensins Human genes 0.000 description 2
- 108010064733 Angiotensins Proteins 0.000 description 2
- 244000201986 Cassia tora Species 0.000 description 2
- 235000014552 Cassia tora Nutrition 0.000 description 2
- 206010013954 Dysphoria Diseases 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 208000007530 Essential hypertension Diseases 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 206010028836 Neck pain Diseases 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 208000002193 Pain Diseases 0.000 description 2
- 102000004270 Peptidyl-Dipeptidase A Human genes 0.000 description 2
- 108090000882 Peptidyl-Dipeptidase A Proteins 0.000 description 2
- 208000009205 Tinnitus Diseases 0.000 description 2
- 201000007930 alcohol dependence Diseases 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 210000000232 gallbladder Anatomy 0.000 description 2
- 235000008216 herbs Nutrition 0.000 description 2
- 230000004377 improving vision Effects 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 230000001965 increasing effect Effects 0.000 description 2
- 210000003127 knee Anatomy 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 230000036581 peripheral resistance Effects 0.000 description 2
- 230000004936 stimulating effect Effects 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 230000009469 supplementation Effects 0.000 description 2
- 231100000886 tinnitus Toxicity 0.000 description 2
- 235000015961 tonic Nutrition 0.000 description 2
- 230000001256 tonic effect Effects 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 239000005541 ACE inhibitor Substances 0.000 description 1
- 239000004382 Amylase Substances 0.000 description 1
- 102000013142 Amylases Human genes 0.000 description 1
- 108010065511 Amylases Proteins 0.000 description 1
- 101710129690 Angiotensin-converting enzyme inhibitor Proteins 0.000 description 1
- 241000235349 Ascomycota Species 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- 101710086378 Bradykinin-potentiating and C-type natriuretic peptides Proteins 0.000 description 1
- VWDXGKUTGQJJHJ-UHFFFAOYSA-N Catenarin Natural products C1=C(O)C=C2C(=O)C3=C(O)C(C)=CC(O)=C3C(=O)C2=C1O VWDXGKUTGQJJHJ-UHFFFAOYSA-N 0.000 description 1
- 206010008479 Chest Pain Diseases 0.000 description 1
- 206010008909 Chronic Hepatitis Diseases 0.000 description 1
- 102000029816 Collagenase Human genes 0.000 description 1
- 108060005980 Collagenase Proteins 0.000 description 1
- 206010010071 Coma Diseases 0.000 description 1
- 208000034656 Contusions Diseases 0.000 description 1
- ZQSIJRDFPHDXIC-UHFFFAOYSA-N Daidzein Natural products C1=CC(O)=CC=C1C1=COC2=CC(O)=CC=C2C1=O ZQSIJRDFPHDXIC-UHFFFAOYSA-N 0.000 description 1
- GMTUGPYJRUMVTC-UHFFFAOYSA-N Daidzin Natural products OC(COc1ccc2C(=O)C(=COc2c1)c3ccc(O)cc3)C(O)C(O)C(O)C=O GMTUGPYJRUMVTC-UHFFFAOYSA-N 0.000 description 1
- KYQZWONCHDNPDP-UHFFFAOYSA-N Daidzoside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C2C(=O)C(C=3C=CC(O)=CC=3)=COC2=C1 KYQZWONCHDNPDP-UHFFFAOYSA-N 0.000 description 1
- 208000003556 Dry Eye Syndromes Diseases 0.000 description 1
- 206010013774 Dry eye Diseases 0.000 description 1
- 239000010282 Emodin Substances 0.000 description 1
- RBLJKYCRSCQLRP-UHFFFAOYSA-N Emodin-dianthron Natural products O=C1C2=CC(C)=CC(O)=C2C(=O)C2=C1CC(=O)C=C2O RBLJKYCRSCQLRP-UHFFFAOYSA-N 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 241000220485 Fabaceae Species 0.000 description 1
- 102000009123 Fibrin Human genes 0.000 description 1
- 108010073385 Fibrin Proteins 0.000 description 1
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 1
- 108010088842 Fibrinolysin Proteins 0.000 description 1
- 208000034507 Haematemesis Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- YOOXNSPYGCZLAX-UHFFFAOYSA-N Helminthosporin Natural products C1=CC(O)=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O YOOXNSPYGCZLAX-UHFFFAOYSA-N 0.000 description 1
- 208000001953 Hypotension Diseases 0.000 description 1
- 206010023644 Lacrimation increased Diseases 0.000 description 1
- 206010024453 Ligament sprain Diseases 0.000 description 1
- 241000234280 Liliaceae Species 0.000 description 1
- 206010058116 Nephrogenic anaemia Diseases 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- 241000180649 Panax notoginseng Species 0.000 description 1
- 235000003143 Panax notoginseng Nutrition 0.000 description 1
- 102000057297 Pepsin A Human genes 0.000 description 1
- 108090000284 Pepsin A Proteins 0.000 description 1
- 102000013566 Plasminogen Human genes 0.000 description 1
- 108010051456 Plasminogen Proteins 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 241000382353 Pupa Species 0.000 description 1
- 208000001647 Renal Insufficiency Diseases 0.000 description 1
- NTGIIKCGBNGQAR-UHFFFAOYSA-N Rheoemodin Natural products C1=C(O)C=C2C(=O)C3=CC(O)=CC(O)=C3C(=O)C2=C1O NTGIIKCGBNGQAR-UHFFFAOYSA-N 0.000 description 1
- 241001107098 Rubiaceae Species 0.000 description 1
- 241001558929 Sclerotium <basidiomycota> Species 0.000 description 1
- 206010041497 Spermatorrhoea Diseases 0.000 description 1
- 240000006698 Spigelia anthelmia Species 0.000 description 1
- 206010041591 Spinal osteoarthritis Diseases 0.000 description 1
- 208000010040 Sprains and Strains Diseases 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 241001601726 Stromatium Species 0.000 description 1
- 206010047139 Vasoconstriction Diseases 0.000 description 1
- 206010047513 Vision blurred Diseases 0.000 description 1
- 229930003448 Vitamin K Natural products 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 235000019418 amylase Nutrition 0.000 description 1
- 229940044094 angiotensin-converting-enzyme inhibitor Drugs 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 230000003276 anti-hypertensive effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 239000002220 antihypertensive agent Substances 0.000 description 1
- 229940127088 antihypertensive drug Drugs 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 230000002457 bidirectional effect Effects 0.000 description 1
- 230000010234 biliary secretion Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 230000004531 blood pressure lowering effect Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 210000000621 bronchi Anatomy 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 208000036319 cervical spondylosis Diseases 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003638 chemical reducing agent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 208000013116 chronic cough Diseases 0.000 description 1
- 229960002424 collagenase Drugs 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 230000009519 contusion Effects 0.000 description 1
- KYQZWONCHDNPDP-QNDFHXLGSA-N daidzein 7-O-beta-D-glucoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C2C(=O)C(C=3C=CC(O)=CC=3)=COC2=C1 KYQZWONCHDNPDP-QNDFHXLGSA-N 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000013872 defecation Effects 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 210000002249 digestive system Anatomy 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 208000017574 dry cough Diseases 0.000 description 1
- RHMXXJGYXNZAPX-UHFFFAOYSA-N emodin Chemical compound C1=C(O)C=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O RHMXXJGYXNZAPX-UHFFFAOYSA-N 0.000 description 1
- VASFLQKDXBAWEL-UHFFFAOYSA-N emodin Natural products OC1=C(OC2=C(C=CC(=C2C1=O)O)O)C1=CC=C(C=C1)O VASFLQKDXBAWEL-UHFFFAOYSA-N 0.000 description 1
- 230000037149 energy metabolism Effects 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 229950003499 fibrin Drugs 0.000 description 1
- 230000020764 fibrinolysis Effects 0.000 description 1
- 239000003527 fibrinolytic agent Substances 0.000 description 1
- 230000003480 fibrinolytic effect Effects 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 201000011066 hemangioma Diseases 0.000 description 1
- 208000006750 hematuria Diseases 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 208000021760 high fever Diseases 0.000 description 1
- 235000012907 honey Nutrition 0.000 description 1
- 230000036543 hypotension Effects 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 201000006370 kidney failure Diseases 0.000 description 1
- 230000004317 lacrimation Effects 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 201000002364 leukopenia Diseases 0.000 description 1
- 231100001022 leukopenia Toxicity 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 108010070324 lumbrokinase Proteins 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 230000036651 mood Effects 0.000 description 1
- 210000004165 myocardium Anatomy 0.000 description 1
- 229940086319 nattokinase Drugs 0.000 description 1
- 108010073682 nattokinase Proteins 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 230000000050 nutritive effect Effects 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 210000000496 pancreas Anatomy 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 229940111202 pepsin Drugs 0.000 description 1
- 210000005259 peripheral blood Anatomy 0.000 description 1
- 239000011886 peripheral blood Substances 0.000 description 1
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 description 1
- PKUBGLYEOAJPEG-UHFFFAOYSA-N physcion Natural products C1=C(C)C=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O PKUBGLYEOAJPEG-UHFFFAOYSA-N 0.000 description 1
- 229940012957 plasmin Drugs 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000029865 regulation of blood pressure Effects 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 229940001941 soy protein Drugs 0.000 description 1
- 208000005801 spondylosis Diseases 0.000 description 1
- 230000004206 stomach function Effects 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000002537 thrombolytic effect Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 229960000716 tonics Drugs 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 239000011345 viscous material Substances 0.000 description 1
- 235000019168 vitamin K Nutrition 0.000 description 1
- 239000011712 vitamin K Substances 0.000 description 1
- 150000003721 vitamin K derivatives Chemical class 0.000 description 1
- 229940046010 vitamin k Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G3/00—Sweetmeats; Confectionery; Marzipan; Coated or filled products
- A23G3/34—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof
- A23G3/36—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds
- A23G3/48—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds containing plants or parts thereof, e.g. fruits, seeds, extracts
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G3/00—Sweetmeats; Confectionery; Marzipan; Coated or filled products
- A23G3/34—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof
- A23G3/36—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds
- A23G3/364—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds containing microorganisms or enzymes; containing paramedical or dietetical agents, e.g. vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G3/00—Sweetmeats; Confectionery; Marzipan; Coated or filled products
- A23G3/34—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof
- A23G3/36—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds
- A23G3/364—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds containing microorganisms or enzymes; containing paramedical or dietetical agents, e.g. vitamins
- A23G3/366—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds containing microorganisms or enzymes; containing paramedical or dietetical agents, e.g. vitamins containing microorganisms, enzymes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G3/00—Sweetmeats; Confectionery; Marzipan; Coated or filled products
- A23G3/34—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof
- A23G3/36—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds
- A23G3/44—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds containing peptides or proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Polymers & Plastics (AREA)
- Inorganic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Nutrition Science (AREA)
- Botany (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines Containing Plant Substances (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
本发明涉及一种可以辅助降血压的小球藻纳豆压片糖果,该小球藻纳豆压片糖果中各原料按照重量份数比为:小球藻15‑25份、纳豆15‑25份、人参3‑7份、三七花3‑7份、栀子3‑7份、葛根8‑12份、蛹虫草4‑6份、决明子4‑6份、黄精4‑6份、枸杞4‑6份、地龙蛋白8‑12份和大豆蛋白肽4‑6份;成品压片糖果中包含小球藻、纳豆、人参、三七花、栀子、葛根、蛹虫草、决明子、黄精、枸杞、地龙蛋白和大豆蛋白肽成分,能够有效的降低服用者的血压,保证服用者精神良好,解除烦闷,增强人体免疫力,可以降低和预防心脑血管病的发病率,清除血液中的垃圾,减少长期服药对肝、肾的损伤,营养心脑、恢复血管弹性。
Description
技术领域
本发明涉及压片糖果加工技术领域,尤其涉及一种可以辅助降血压的小球藻纳豆压片糖果。
背景技术
传统的糖果类食品只能满足人们补充营养以及食物多样化方面的需求,通常只注重色香味等方面的要求,其包含的营养成分往往只注重补充能力的需求,当今社会,高血压成为一种常见疾病,高血压是持续血压过高的疾病,会引起中风、心脏病、血管瘤、肾衰竭等疾病。
发明内容
本发明解决的问题在于提供一种可以辅助降血压的小球藻纳豆压片糖果,通过小球藻、纳豆、人参、三七花、栀子、葛根8-12份、蛹虫草、决明子、黄精、枸杞、地龙蛋白和大豆蛋白肽为原料加工制得压片糖果,能够起到降低血压、增强人体免疫力的功效。
为了实现上述目的,本发明采用了如下技术方案:
一种可以辅助降血压的小球藻纳豆压片糖果,该小球藻纳豆压片糖果中各原料按照重量份数比为:小球藻15-25份、纳豆15-25份、人参3-7份、三七花3-7份、栀子3-7份、葛根8-12份、蛹虫草4-6份、决明子4-6份、黄精4-6份、枸杞4-6份、地龙蛋白8-12份和大豆蛋白肽4-6份。
优选的,所述小球藻纳豆压片糖果的具体制备方法如下:
S1:将纳豆进行粉碎干燥、过40-80目筛;
S2:将小球藻、人参、三七花、栀子、葛根、蛹虫草、决明子、黄精和枸杞切碎,然后将切碎后的小球藻、人参、三七花、栀子、葛根、蛹虫草、决明子、黄精和枸杞进行粉碎,过40-80目筛;
S3:将S2中的各原料细粉混合均匀,通过制粒机进行制粒,70-80℃温度烘烤至水分为0.5-2%,通过整粒机进行整粒,将整粒后的颗粒加入纳豆粉、地龙蛋白和大豆蛋白肽混合均匀,进行压片、包装,制成成品压片糖果。
优选的,所述纳豆粉活性为2000FU/g。
优选的,所述成品压片糖果的厚度为3.0-7.0mm。
本发明的有益效果是:成品压片糖果中包含小球藻、纳豆、人参、三七花、栀子、葛根、蛹虫草、决明子、黄精、枸杞、地龙蛋白和大豆蛋白肽成分,能够有效的降低服用者的血压,保证服用者精神良好,解除烦闷,增强人体免疫力,可以降低和预防心脑血管病的发病率,清除血液中的垃圾,减少长期服药对肝、肾的损伤,营养心脑、恢复血管弹性。
具体实施方式
对本发明实施例中的技术方案进行清楚、完整地描述,显然,所描述的实施例仅仅是本发明一部分实施例,而不是全部的实施例。基于本发明中的实施例,本领域普通技术人员在没有作出创造性劳动前提下所获得的所有其它实施例,都属于本发明保护的范围。
下面给出具体实施例。
实施例一
一种可以辅助降血压的小球藻纳豆压片糖果,该小球藻纳豆压片糖果中各原料按照重量份数比为:小球藻15份、纳豆25份、人参7份、三七花7份、栀子7份、葛根12份、蛹虫草6份、决明子6份、黄精6份、枸杞6份、地龙蛋白12份和大豆蛋白肽6份;
小球藻纳豆压片糖果的具体制备方法如下:
S1:将纳豆进行粉碎干燥、过40-80目筛,纳豆粉活性为2000FU/g;
S2:将小球藻、人参、三七花、栀子、葛根、蛹虫草、决明子、黄精和枸杞切碎,然后将切碎后的小球藻、人参、三七花、栀子、葛根、蛹虫草、决明子、黄精和枸杞进行粉碎,过40-80目筛;
S3:将S2中的各原料细粉混合均匀,通过制粒机进行制粒,70-80℃温度烘烤至水分为0.5-2%,通过整粒机进行整粒,将整粒后的颗粒加入纳豆粉、地龙蛋白和大豆蛋白肽混合均匀,进行压片、包装,制成成品压片糖果,成品压片糖果的厚度为3.0-7.0mm。
实施例二
一种可以辅助降血压的小球藻纳豆压片糖果,该小球藻纳豆压片糖果中各原料按照重量份数比为:小球藻25份、纳豆15份、人参3份、三七花3份、栀子3份、葛根8份、蛹虫草4份、决明子4份、黄精4份、枸杞4份、地龙蛋白8份和大豆蛋白肽4份;
小球藻纳豆压片糖果的具体制备方法如下:
S1:将纳豆进行粉碎干燥、过40-80目筛,纳豆粉活性为2000FU/g;
S2:将小球藻、人参、三七花、栀子、葛根、蛹虫草、决明子、黄精和枸杞切碎,然后将切碎后的小球藻、人参、三七花、栀子、葛根、蛹虫草、决明子、黄精和枸杞进行粉碎,过40-80目筛;
S3:将S2中的各原料细粉混合均匀,通过制粒机进行制粒,70-80℃温度烘烤至水分为0.5-2%,通过整粒机进行整粒,将整粒后的颗粒加入纳豆粉、地龙蛋白和大豆蛋白肽混合均匀,进行压片、包装,制成成品压片糖果,成品压片糖果的厚度为3.0-7.0mm。
实施例三
一种可以辅助降血压的小球藻纳豆压片糖果,该小球藻纳豆压片糖果中各原料按照重量份数比为:小球藻20份、纳豆20份、人参5份、三七花5份、栀子5份、葛根10份、蛹虫草5份、决明子5份、黄精5份、枸杞5份、地龙蛋白10份和大豆蛋白肽5份;
小球藻纳豆压片糖果的具体制备方法如下:
S1:将纳豆进行粉碎干燥、过40-80目筛,纳豆粉活性为2000FU/g;
S2:将小球藻、人参、三七花、栀子、葛根、蛹虫草、决明子、黄精和枸杞切碎,然后将切碎后的小球藻、人参、三七花、栀子、葛根、蛹虫草、决明子、黄精和枸杞进行粉碎,过40-80目筛;
S3:将S2中的各原料细粉混合均匀,通过制粒机进行制粒,70-80℃温度烘烤至水分为0.5-2%,通过整粒机进行整粒,将整粒后的颗粒加入纳豆粉、地龙蛋白和大豆蛋白肽混合均匀,进行压片、包装,制成成品压片糖果,成品压片糖果的厚度为3.0-7.0mm。
成品压片糖果中包含小球藻、纳豆、人参、三七花、栀子、葛根、蛹虫草、决明子、黄精、枸杞、地龙蛋白和大豆蛋白肽成分,能够有效的降低服用者的血压,保证服用者精神良好,解除烦闷,增强人体免疫力,可以降低和预防心脑血管病的发病率,清除血液中的垃圾,减少长期服药对肝、肾的损伤,营养心脑、恢复血管弹性。
小球藻:具有抑制脂肪吸收,刺激高脂肪食品排出的功能。
纳豆中的纤维素、活性酶等成分具有健脾消食的功效,能够增强脾胃功能,调节肠道菌群的微生态平衡,改善食欲不振、便秘的症状;纳豆的黏性物质中含有血管紧张肽转化酶抑制剂,能够降低血压,适合高血压患者食用;纳豆中的纳豆激酶具有溶栓功效,能预防血栓性疾病。此外,纳豆中含有大量的维生素K,能将血钙转换为骨钙,提高人体对钙的吸收,预防骨质疏松。
人参具有抗休克、增强免疫功能、抗肿瘤、抗辐射、降血脂、降血糖、抗利尿等作用;此外,人参还能够增强消化、吸收功能,提高胃蛋白酶活性,保护胃肠细胞,改善脾虚症状。现代应用人参配伍,可以治疗糖尿病、白细胞减少、慢性肝炎、肾性贫血等疾病。
三七花性凉,味甘、微苦,归肺、肾经,能够凉血降压,还有降脂之效,可以缓解头晕目眩、耳鸣神昏、高血压等。
栀子为中药材,是茜草科植物栀子的果实,栀子味苦性寒,归心肺三焦经,具有较高的药用价值,可以泻火、凉血、利湿及促胰腺分泌,常用于治疗黄疸型肝炎、高血压、糖尿病或者是扭挫伤等病症;
泻火:栀子的泻火功效强,可改善忧心伤神的症状,尤其适用于热扰心神的症状,对于体外的热感病症也有很好的治疗作用,可解除烦闷,缓解邪郁上焦及高热烦躁等现象;
凉血:栀子的解毒效果比较明显,可以防治各种热毒,还可起到凉血作用,有助于缓解吐血及尿血现象,改善热毒带来的毒疮症状;
利湿:栀子的利湿功效很强,可有效清除肝胆湿热。如肝火旺盛,情绪烦躁,伴随胸闷和口苦等症状,可以服用栀子来改善;
促胰腺分泌:栀子对胰腺分泌也有良好的促进作用,能抑制胰淀粉酶的作用,增加胰胆分泌。
葛根,中药名,为豆科植物野葛的干燥艮,习称野葛,秋、冬二季采挖,趁鲜切成厚片或小块,干燥,味甘、辛,性凉,归脾、胃、肺经,具有解肌退热、生津止渴、解酒毒等功效;
解肌退热:葛根具有解肌退热的功效,可以用来治疗外感发热,项背强痛,对于高血压和颈椎病引起的头项强痛也有很好的疗效;
生津止渴:葛根具有生津止渴之功效,可用于治疗消渴病,常与天花粉、麦门冬、鲜地黄等同用;
解酒毒:葛根含有大豆甙,能有效分解酒精,减少其对大脑和肠胃的刺激,促进代谢,加速排解酒精以及残留在肝胆中的毒素,从而起到保护肝脏的作用。
蛹虫草是由子座与菌核两部分组成的复合体,蛹虫草是一种子囊菌,不仅具有营养价值,而且有一定的药用价值,是一种能同时平衡、调节阴阳的中药,具有降压、补肺益气、护心养脑等功效;
降压:蛹虫草可以扩张血管、降血脂,有降压的作用,所以蛹虫草对改善高血压有一定疗效;
补肺益气:蛹虫草具有很强的抗炎作用,可以清除肺内、支气管内的宿痰和垃圾,改善呼吸系统,适量食用还可以补肺益气;
护心养脑:蛹虫草被誉为心脑血管的保护神,可以降低和预防心脑血管病的发病率,清除血液中的垃圾,减少长期服药对肝、肾的损伤,营养心肌、恢复血管弹性。
决明子是豆科植物决明或小决明的干燥成熟种子,以其有明目之功而名之,秋季采收成熟果实,晒干,打下种子,除去杂质;决明子味苦、甘、咸,性微寒,入肝、肾、大肠经,具有清热解毒、缓解便秘、清肝明目的功效;
清热解毒:决明子中含有的大黄素能够帮助清热、润肠,决明子滋阴清热,对于内热造成的排便不畅,毒素堆积也有很好的缓解效果;缓解便秘:决明子性寒,能够清热滋阴、缓解便秘,可以用蜂蜜搭配决明子一起泡水喝更好的润肠、清热、通便,以缓解便秘;
清肝明目:决明子性微寒,入肝、肾,能够有效清肝明目,需要长时间用眼或者是经常眼睛干涩、胀痛等不适的人,可以多食用决明子以缓解眼睛不适。
黄精属中药材,为百合科草本植物黄精、滇黄精或多花黄精的根茎,生林下、灌丛或山坡阴处,秋季采收,挖取根茎,取出晒干;黄精色黄质润,味厚气薄,为平、补之剂,具有滋阴润肺、补益脾气、益肾精等功效;
滋阴润肺:黄精滋阴润肺,可用于阴虚肺燥、干咳少痰及肺肾阴虚的劳嗽久咳,对于阴虚肺燥干咳少痰或肺肾阴虚之劳嗽久咳,本品不仅能补益肺肾之阴,而且能补益脾气脾阴。多单用熬膏服用,亦可与滋养肺肾、化痰止咳之品同用;
补益脾气:黄精具有补脾益气的功效,可用于脾脏气阴两虛之面色菱黄、困倦乏力、口干食少、大便干燥等症,对于脾脏气阴两虚证,本品能气阴双补,用之则较为适宜,尤宜用作久病或病后调补之品服食,单用或与补气健脾药同用;
益肾精:黄精入肾经,益肾精,可用于治疗肾精亏虚早衰,本品能补益肾精,以延缓衰老,改善头晕、腰膝酸软、须发早白等早衰症状,蒸熟或熬膏长期服用疗效显著。
生吃枸杞有滋补肝肾的作用,能够缓解肝肾不足引起的乏力、腰膝酸软、头晕、耳鸣、遗精;枸杞的明目效果也比较理想,对长时间用眼、肝肾不足引起的目眩、视物模糊、多泪有治疗效果;枸杞还有润肺的作用,虚劳咳嗽、消渴的患者可以生吃枸杞,有助于改善症状;现代医学研究还发现枸杞还有增强免疫力、抗衰老、抗肿瘤等作用。地龙蛋白提取自地龙,含有胶原酶、纤溶酶、蚓激酶、纤溶激活蛋白、核酸、微量元素等多种成分,属于短链小分子物质。地龙蛋白对体内的凝血系统和纤溶系统具有广泛的影响,具有溶解血栓、双向调节血压、降低血糖等功效;
溶解血栓:地龙蛋白富含纤维蛋白溶解酶,可激活血栓中的纤维蛋白溶解酶原,使之转化为具有活性的纤维蛋白溶解酶,进溶解血栓中的纤维蛋白,把新鲜的血栓溶解,本品中的纤维蛋白溶解酶又可直接溶解血栓,把陈旧性的血栓溶解:
双向调节血压:活性地龙蛋白通过恢复血液弹性、溶解血栓、改善微循环而改善管围状态,降低血流外周阻力,降低血液黏稠度而具有稳定的降压作用,原发性高血压患者服用后,可控制血压接近正常的水平;重度高血压病或心脑血管并发高血压,服本品后能增强其它降压药的降压作用,同时本品通过改善血液质量和外周阻力,对低血压具有调节作用;
降低血糖:地龙蛋白可改善人体多种机能,改善机体的内环境,促进胰岛功能的恢复,服本品后有降糖作用。
大豆蛋白肽的功效:易被人体吸收、提高肌体免疫力,大豆蛋白肽中70%以上是由二到三个氨基酸组成小分子肽,现代医学研究发现,人体消化系统存在一个蛋白肽运转体系,小分子肽可以由肠道直接吸收,快速进入到血液中,被输送到人体所需要的部位,肽分子进入人体后能继续保持生物活性,直接参与和调节人体重要的生命活动;因此大豆蛋白肽能快速补充营养,消除疲劳,加速人体内免疫蛋白的合成,增强人体免疫力,在人体疲劳、虚弱、免疫系统遭到破坏时,效果尤其明显;安全降压,由于血管中血管紧张素转换酶能使血管紧张素转换,导致末梢血管收缩,血压升高;大豆蛋白肽通过抑制血管紧张素转换酶活性的作用,达到阻止血管紧张素转换的效果,因此可防止末梢血管的过度收缩,达到降血压的作用。它的降压过程平稳,不会出现药物降压带来的波动对患者造成的疼痛感,对高压、心血管疾病的患者,尤其是原发性高血压患者有显著效果;大豆蛋白肽对血压正常者没有降压作用,对正常人是无害的,可以放心食用;降低血脂、抑制胆固醇,大豆蛋白肽在降低人体血清胆固醇方面,具有独到特点:对高胆固醇者有明显的降低作,即它能降低对人体有害的低密度胆固醇值,而不降低对人体有益的高密度胆固醇直,对于胆固醇正常的人也没有降低作用,当他们在食用高胆固醇食物时,大豆蛋白肽还有处于防止血清胆固醇的升高:促进脂肪代谢,具有减肥作用,大豆蛋白肽能刺激产生热能的脂肪组织的活性,增加散热量。正是由于大豆蛋白肽具有促进脂肪和能量代谢的作用,并能抑制体内脂肪的贮存,再加上大豆蛋白肽的降糖效果,因此长期食用大豆蛋白肽能有效地控制体重的增加,起到很好的预防肥胖和减肥的作用。
以上所述,仅为本发明较佳的具体实施方式,但本发明的保护范围并不局限于此,任何熟悉本技术领域的技术人员在本发明揭露的技术范围内,根据本发明的技术方案及其发明构思加以等同替换或改变,都应涵盖在本发明的保护范围内。
Claims (4)
1.一种可以辅助降血压的小球藻纳豆压片糖果,其特征在于,该小球藻纳豆压片糖果中各原料按照重量份数比为:小球藻15-25份、纳豆15-25份、人参3-7份、三七花3-7份、栀子3-7份、葛根8-12份、蛹虫草4-6份、决明子4-6份、黄精4-6份、枸杞4-6份、地龙蛋白8-12份和大豆蛋白肽4-6份。
2.根据权利要求1所述的一种可以辅助降血压的小球藻纳豆压片糖果,其特征在于,所述小球藻纳豆压片糖果的具体制备方法如下:
S1:将纳豆进行粉碎干燥、过40-80目筛;
S2:将小球藻、人参、三七花、栀子、葛根、蛹虫草、决明子、黄精和枸杞切碎,然后将切碎后的小球藻、人参、三七花、栀子、葛根、蛹虫草、决明子、黄精和枸杞进行粉碎,过40-80目筛;
S3:将S2中的各原料细粉混合均匀,通过制粒机进行制粒,70-80℃温度烘烤至水分为0.5-2%,通过整粒机进行整粒,将整粒后的颗粒加入纳豆粉、地龙蛋白和大豆蛋白肽混合均匀,进行压片、包装,制成成品压片糖果。
3.根据权利要求2所述的一种可以辅助降血压的小球藻纳豆压片糖果,其特征在于,所述纳豆粉活性为2000FU/g。
4.根据权利要求2所述的一种可以辅助降血压的小球藻纳豆压片糖果,其特征在于,所述成品压片糖果的厚度为3.0-7.0mm。
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202311713512.8A CN117730935A (zh) | 2022-03-23 | 2022-03-23 | 一种小球藻纳豆压片糖果的制备方法及应用 |
CN202210292633.9A CN114642236A (zh) | 2022-03-23 | 2022-03-23 | 一种可以辅助降血压的小球藻纳豆压片糖果 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210292633.9A CN114642236A (zh) | 2022-03-23 | 2022-03-23 | 一种可以辅助降血压的小球藻纳豆压片糖果 |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202311713512.8A Division CN117730935A (zh) | 2022-03-23 | 2022-03-23 | 一种小球藻纳豆压片糖果的制备方法及应用 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN114642236A true CN114642236A (zh) | 2022-06-21 |
Family
ID=81995633
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202311713512.8A Pending CN117730935A (zh) | 2022-03-23 | 2022-03-23 | 一种小球藻纳豆压片糖果的制备方法及应用 |
CN202210292633.9A Pending CN114642236A (zh) | 2022-03-23 | 2022-03-23 | 一种可以辅助降血压的小球藻纳豆压片糖果 |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202311713512.8A Pending CN117730935A (zh) | 2022-03-23 | 2022-03-23 | 一种小球藻纳豆压片糖果的制备方法及应用 |
Country Status (1)
Country | Link |
---|---|
CN (2) | CN117730935A (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115644295A (zh) * | 2022-11-12 | 2023-01-31 | 谢祥春 | 纯植物食品级降血压压片糖果的制作过程 |
Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103211150A (zh) * | 2013-05-17 | 2013-07-24 | 胡凯 | 一种含活性地龙蛋白的多肽食品 |
CN109043098A (zh) * | 2018-07-24 | 2018-12-21 | 天津民生生物工程股份有限公司 | 一种食用地龙蛋白压片糖果及其加工工艺 |
CN109315576A (zh) * | 2018-10-12 | 2019-02-12 | 肖文中 | 纳豆竹叶黄酮压片糖果 |
CN109498803A (zh) * | 2018-11-19 | 2019-03-22 | 刘神剑 | 治疗三高和心脏血管疾病的中药组合物及其制备方法 |
CN109757598A (zh) * | 2019-01-24 | 2019-05-17 | 江苏金丝利药业股份有限公司 | 一种纳豆桑叶压片糖果及其制备方法 |
CN111357858A (zh) * | 2019-09-18 | 2020-07-03 | 广州市好孝心医疗器械有限公司 | 一种具有溶血栓和软化血管功能的复合多肽地龙蛋白压片糖果及其制备方法 |
CN112690390A (zh) * | 2021-01-08 | 2021-04-23 | 江苏中堂健康管理有限公司 | 人参蛹虫草固体饮料及其制备方法 |
CN113855766A (zh) * | 2021-10-09 | 2021-12-31 | 江苏华尔康生物制品有限公司 | 一种可调理血压的银杏蛹虫草冲剂 |
CN114159529A (zh) * | 2022-01-22 | 2022-03-11 | 张发升 | 一种用于高血压防治的组合物及其制备方法 |
-
2022
- 2022-03-23 CN CN202311713512.8A patent/CN117730935A/zh active Pending
- 2022-03-23 CN CN202210292633.9A patent/CN114642236A/zh active Pending
Patent Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103211150A (zh) * | 2013-05-17 | 2013-07-24 | 胡凯 | 一种含活性地龙蛋白的多肽食品 |
CN109043098A (zh) * | 2018-07-24 | 2018-12-21 | 天津民生生物工程股份有限公司 | 一种食用地龙蛋白压片糖果及其加工工艺 |
CN109315576A (zh) * | 2018-10-12 | 2019-02-12 | 肖文中 | 纳豆竹叶黄酮压片糖果 |
CN109498803A (zh) * | 2018-11-19 | 2019-03-22 | 刘神剑 | 治疗三高和心脏血管疾病的中药组合物及其制备方法 |
CN109757598A (zh) * | 2019-01-24 | 2019-05-17 | 江苏金丝利药业股份有限公司 | 一种纳豆桑叶压片糖果及其制备方法 |
CN111357858A (zh) * | 2019-09-18 | 2020-07-03 | 广州市好孝心医疗器械有限公司 | 一种具有溶血栓和软化血管功能的复合多肽地龙蛋白压片糖果及其制备方法 |
CN112690390A (zh) * | 2021-01-08 | 2021-04-23 | 江苏中堂健康管理有限公司 | 人参蛹虫草固体饮料及其制备方法 |
CN113855766A (zh) * | 2021-10-09 | 2021-12-31 | 江苏华尔康生物制品有限公司 | 一种可调理血压的银杏蛹虫草冲剂 |
CN114159529A (zh) * | 2022-01-22 | 2022-03-11 | 张发升 | 一种用于高血压防治的组合物及其制备方法 |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115644295A (zh) * | 2022-11-12 | 2023-01-31 | 谢祥春 | 纯植物食品级降血压压片糖果的制作过程 |
Also Published As
Publication number | Publication date |
---|---|
CN117730935A (zh) | 2024-03-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN107296949A (zh) | 药食同源复合制剂及其制备方法和应用 | |
CN105582333A (zh) | 一种养生补肾黄秋葵酒及其制备方法 | |
CN107865181A (zh) | 中药酵素压片糖果及其制作方法 | |
CN110840966A (zh) | 一种用于解酒的组合物及包含其的咀嚼片 | |
CN110151983A (zh) | 一种用于补肾益气的中药制剂及其制备方法 | |
CN101946895A (zh) | 一种以泥鳅为主料的功能食品及其制备方法 | |
CN108853342A (zh) | 一种治疗糖尿病的中药提取物和制备方法 | |
CN109170476A (zh) | 含有菊苣的保健食品 | |
CN114642236A (zh) | 一种可以辅助降血压的小球藻纳豆压片糖果 | |
CN116509971A (zh) | 一种具有益智效果的中药组方、中药液和药物制剂 | |
CN106860814B (zh) | 一种改善女性尿频、尿失禁的保健食品组合物及其制备方法和应用 | |
CN106177166A (zh) | 一种具有缓解体力疲劳功能的组合物及其制备方法 | |
CN108721407A (zh) | 一种气阳两虚体质调理足浴粉及其制备方法 | |
CN115089661A (zh) | 辅助调节内分泌代谢并抗癌防癌的人参组合物的应用 | |
CN106579384A (zh) | 一种具有分解脂肪作用的综合酵素粉及其制备方法 | |
CN102988747B (zh) | 一种三刺降三高的冲剂及其制备方法 | |
CN111658720A (zh) | 用于养生的中药组合物、养生丸以及制备方法 | |
CN105902867B (zh) | 一种降三高的植物药组合物及其制备方法 | |
CN105748823A (zh) | 一种美容养颜中药组合物及其制备方法 | |
CN111296599A (zh) | 一种具有辅助降血糖作用的中药养生茶及其制备方法 | |
CN116251152B (zh) | 用于生发乌发的中药组合物、中药制剂的制备方法以及应用 | |
CN115006460B (zh) | 一种解酒护肝中药组合物及其制备方法和应用 | |
CN106266427A (zh) | 一种治疗肾病的中药药酒及其制备方法 | |
CN106262801A (zh) | 一种防治血栓性静脉炎的营养配方纳米颗粒及制备加工方法 | |
CN106174011A (zh) | 一种防治糖尿病的营养配方纳米颗粒及制备加工方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20220621 |